Atlas Trials

Study of Fluzone® Quadrivalent, Fluzone® Intradermal, and Fluzone® High-Dose Influenza Virus Vaccines in Adults

Clinical trial NCT01946438 · COMPLETED

Trial details

NCT number
NCT01946438
Sponsor
Sanofi Pasteur, a Sanofi Company
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Influenza
Start date
2013-09-01
Primary completion
2013-12-01
Enrollment
208

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.